Sitagliptin improved glycemic control and beta-cell function in type 2 diabetes
- PMID: 17335162
Sitagliptin improved glycemic control and beta-cell function in type 2 diabetes
Comment on
-
Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes.Diabetes Care. 2006 Dec;29(12):2632-7. doi: 10.2337/dc06-0703. Diabetes Care. 2006. PMID: 17130196 Clinical Trial.